Views & Analysis

Biomarkers have been causing a paradigm shift in how HCPs treat patients for some time – now they

How biomarkers and bioanalytics are changing R&D

https://pharmaphorum.com/patients/how-biomarkers-and-bioanalytics-are-changing-rd/

Deep Dive/ Patients/ Views & Analysis/ Views and analysis

Health literacy for the intellectually disabled: is pharma doing enough?

mike.hammerton@pharmaphorum.com Deep Dive, Deep Dive: Patients and Partnerships, health literacy, Olivia Kersey, Patients and Partnerships, Prime Global 0 Comment

What is health literacy and why is it important? Health literacy (HL), defined by the CDC as the

Health literacy for the intellectually disabled: is pharma doing enough?

https://pharmaphorum.com/patients/prime-global-health-literacy-intellectually-disabled-pharma/

Deep Dive/ Patients/ Views & Analysis/ Views and analysis

Leveraging real-world data to meet payers’ needs

mike.hammerton@pharmaphorum.com Certara, Deep Dive, Deep Dive: Patients and Partnerships, Lee Stern, Patients and Partnerships, real world data, Shawn Bates 0 Comment

Payers are becoming savvier in accepting real-world data. Certara’s Lee Stern and Shawn Bates discuss the challenges and

Leveraging real-world data to meet payers’ needs

https://pharmaphorum.com/patients/leveraging-real-world-data-meet-payers-needs/

Patients/ Views & Analysis/ Views and analysis

Time for change: PhRMA survey shows insurance creates barriers to healthcare in US

Amanda Barrell patient experience, PhRMA, survey 0 Comment

Health insurance is not enough to provide the necessary affordable access to care for the US’ most vulnerable,

Time for change: PhRMA survey shows insurance creates barriers to healthcare in US

https://pharmaphorum.com/patients/phrma-survey-insurance-creates-barriers-to-healthcare-in-us/

Deep Dive/ Patients/ Views & Analysis/ Views and analysis

Time for a new model in patient access

mike.hammerton@pharmaphorum.com Astellas, Astellas Pharma Europe, Deep Dive, Deep Dive: Patients and Partnerships, Mig Sleeper, Patients and Partnerships 0 Comment

Mig Sleeper, vice president, Global Pricing for Astellas Pharma Europe, explains why we must rethink how value is

Time for a new model in patient access

https://pharmaphorum.com/patients/time-for-a-new-model-in-patient-access/

Deep Dive/ Patients/ Views & Analysis/ Views and analysis

Time to take patient engagement to the next level

mike.hammerton@pharmaphorum.com Dawn Lobban, Deep Dive, Deep Dive: Patients and Partnerships, Envision Pharma, Patients and Partnerships, Sarah Avent 0 Comment

Patient engagement in pharma is evolving, with some companies doing it better than others. Envision Pharma Group’s Dawn

Time to take patient engagement to the next level

https://pharmaphorum.com/patients/envision-pharma-patient-engagement-next-level/

Patients/ Views & Analysis/ Views and analysis

UK-wide whole genome sequencing for newborns is feasible – but there are some key questions to answer first

mike.hammerton@pharmaphorum.com AstraZeneca, COVID-19, EFPIA, healthcare, HTA, NICE, sustainable healthcare 0 Comment

Genomics England, the Department of Health and Social Care’s genome-sequencing hub, has this year announced that support for

UK-wide whole genome sequencing for newborns is feasible – but there are some key questions to answer first

https://pharmaphorum.com/patients/public-approval-whole-genome-sequencing-newborn-screenings-uk-wide-rollout/

Deep Dive/ Patients/ Views & Analysis/ Views and analysis

Patients want to be heard. Is pharma listening?

mike.hammerton@pharmaphorum.com Axon, Deep Dive, Deep Dive: Patients and Partnerships, Natalie Turner, Patients and Partnerships 0 Comment

A common theme heard from the advocacy groups AXON works with is “Nothing for us without us,” says

Patients want to be heard. Is pharma listening?

https://pharmaphorum.com/patients/patients-want-to-be-heard-pharma-axon/

Deep Dive/ Patients/ Views & Analysis/ Views and analysis

Three views on technology improving clinical trial efficiency

mike.hammerton@pharmaphorum.com Deep Dive, Deep Dive: Patients and Partnerships, Marie Emms, Patients and Partnerships, syneos health 0 Comment

Marie Emms, vice president of site and patient participation at Syneos Health, tells us technology helped increase patient

Three views on technology improving clinical trial efficiency

https://pharmaphorum.com/patients/three-views-on-technology-improving-clinical-trial-efficiency/

«‹ 4 5 6 7 ›»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

Views & Analysis

Login